Clinical Trial Update: Achieving Portal Access With Scorpion Post-Approval Study 2

View source ↗

Summary

The Scorpion post-approval study 2 has completed, evaluating portal access with Argon Medical Devices' Scorpion system in patients with portal hypertension and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Ascites
• Hepatic Hydrothorax
• Liver Diseases
• Portal Hypertension
• Vascular Diseases

Drugs mentioned

• Scorpion Portal Access System

Snippet

Sponsor: Argon Medical Devices | Conditions: Portal Hypertension, Liver Diseases | Status: COMPLETED